| Name | Title | Contact Details |
|---|
BID Needham, part of Beth Israel Lahey Health, is focused on providing our patients with easy access to compassionate, safe and high-quality health care.
NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington`s disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been “undruggable.” for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase`s pipeline includes
Pharmacore is a High Point, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Hikma we put better health within reach, every day. We create high quality medicines, and we make them accessible and affordable to the people who need them.